Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 21/12/19941 min de lectura
Animal Drugs, Feeds, and Related Products; Albendazole Suspension
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by SmithKline Beecham Animal Health Products. The NADA provides for use of albendazole suspension (Valbazen ) as an anthelmintic in sheep. The regulations are also amended to establish a tolerance for albendazole residue in sheep liver.
Idioma original de la fuente: Federal Register — Health and Human ServicesAbrir el comunicado original →